CD24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma

CD24 has been described as an adverse prognostic marker in several malignancies. This study evaluates CD24 expression in cholangiocarcinoma and correlates the findings with clinicopathologic data and patient survival. Between 1996 and 2002, 22 consecutive patients with cholangiocarcinoma were treate...

Full description

Saved in:
Bibliographic Details
Main Authors: Agrawal, Shefali, Kuvshinoff, Boris W., Khoury, Thaer, Yu, Jihnhee, Javle, Milind M., LeVea, Charles, Groth, Jeff, Coignet, Lionel J., Gibbs, John F.
Format: Artigo
Language:Inglês
Published: Springer-Verlag 2007
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1852393/
https://ncbi.nlm.nih.gov/pubmed/17436128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11605-007-0091-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items